Skip to main content Back to Top
Advertisement

5/26/2016

Acetaminophen and Codeine Phosphate 300 mg/30 mg Tablets

Products Affected - Description

    • Acetaminophen and Codeine tablet, Aurobindo, 300 mg/ 30 mg, 100 count, NDC 13170-0059-01
    • Acetaminophen and Codeine tablet, Mylan Institutional, 300 mg/ 30 mg, unit-dose 100 count, NDC 51079-0161-21

Reason for the Shortage

    • Mallinckrodt has acetaminophen and codeine tablets available but allocates product to wholesalers based on previous order history.
    • Qualitest will not provide shortage information for any of their products because they consider the information to be proprietary.

Available Products

    • Tylenol with Codeine #3 tablet, Janssen, 300 mg/ 30 mg, 100 count, NDC 50458-0513-60
    • Tylenol with Codeine #3 tablet, Janssen, 300 mg/ 30 mg, 1000 count, NDC 50458-0513-80
    • Acetaminophen and Codeine tablet, Amneal, 300 mg/ 30 mg, 100 count, NDC 65162-0033-10
    • Acetaminophen and Codeine tablet, Amneal, 300 mg/ 30 mg, 1000 count, NDC 65162-0033-11
    • Acetaminophen and Codeine tablet, Aurobindo, 300 mg/ 30 mg, 1000 count, NDC 13107-0059-99
    • Acetaminophen and Codeine tablet, Mallinckrodt, 300 mg/ 30 mg, 30 count, NDC 00406-0484-03
    • Acetaminophen and Codeine tablet, Mallinckrodt, 300 mg/ 30 mg, 100 count, NDC 00406-0484-01
    • Acetaminophen and Codeine tablet, Mallinckrodt, 300 mg/ 30 mg, unit-dose 100 count, NDC 00406-0484-62
    • Acetaminophen and Codeine tablet, Mallinckrodt, 300 mg/ 30 mg, 1000 count, NDC 00406-0484-10
    • Acetaminophen and Codeine tablet, Mylan Institutional, 300 mg/ 30 mg, unit-dose 100 count, NDC 51079-0161-20
    • Acetaminophen and Codeine tablet, Teva, 300 mg/ 30 mg, 100 count, NDC 00093-0150-01
    • Acetaminophen and Codeine tablet, Teva, 300 mg/ 30 mg, 1000 count, NDC 00093-0150-10

Estimated Resupply Dates

    • Mallinckrodt has acetaminophen and codeine 300 mg/30 mg tablets available and allocated product monthly to wholesalers based on previous order history.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 7, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins